FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W628846560> ?p ?o ?g. }

• W628846560 abstract "Introduction: Y S Cho-Chung, Alan M. Gewirtz, and Cy A. Stein. Part I: Kill the Messenger: Gene Silencing by Nucleic Acid Molecules. 1. Knock-down of the Cytoprotective Gene, Clusterin, to Enhance Hormone and Chemosensitivity in Prostate and Other Cancers: Martin Gleave and Kim N. Chi. 2. Recognition of Chromosomal DNA in Human Cells by Peptide Nucleic Acids and Small Duplex RNAs: David R. Corey. Part II: Antisense and siRNA: Chemistry, Sequence Specificity, and Target Validation. 3. Design and Development of Thermolytic DNA Oligonucleotide Prodrugs: Andrzej Grajkowski, Joao Pedras-Vasconcelos, Cristina Ausin, Daniela Verthelyi, and Serge L. Beaucage. 4. Rationally Targeted, Conformationally Constrained, Oxetane-Modified Oligonucleotides Demonstrate Efficient Gene-Silencing Activity in a Cellular System: J B Opalinska and A M Gewirtz. Part III: Delivery Cellular and Phenotype Effect of Silencing Agents:. 5. In Vivo Potentialities Andrei Maksimenko, Valerie Polard, Marie Villemeur, Hind Elhamess, Patrick Couvreur, Jean-Remi Bertrand, Malam Aboubakar, Marina Gottikh, and Claude Malvy of EWS-Fli-1 Targeted Antisense Oligonucleotides-Nanospheres Complexes:. 6. Endo-Porter: A Novel Reagent for Safe, Effective Delivery of Substances into Cells: James E. Summerton. 7. Tumor Reversion: Protein Kinase A Isozyme Switching: Yoon S. Cho-Chung and Maria V. Nesterova. Part IV: Immune Modulation of and Resistance to Silencing Agents. 8. Therapeutic Potential of Oligonucleotides Expressing Immunosuppressive TTAGGG Motifs: Dennis M. Klinman, Ihsan Gursel, Sven Klaschik, Li Dong, Debbie Currie, and Hidekazu Shirota. 9. Breaking Tolerance to Tumors with Dendritic Cell-Based Immunotherapy: Ines Mende and Edgar G. Engleman. 10. Development of Resistance to RNAi in Mammalian Cells: Zhi-Ming Zheng, Shuang Tang, and Mingfang Tao. Part V: Transcription Silencing by Nucleic Acid Molecules. 11. The Development of Bioactive Triple Helix-Forming Oligonucleotides: Michael M. Seidman, Nitin Puri, Alokes Majumdar, Bernard Cuenoud, Paul S. Miller, and Rowshon Alam. 12. Transcription Factor Decoys: A New Model for Disease Intervention: Michael J. Mann. 13. DNA Damage Produced by 125I-Triplex-Forming Oligonucleotides as a Measure of Their Succesful Delivery into Cell Nuclei: Irina V. Panyutin, Olga A. Sedelnikova, William M. Bonner, Igor G. Panyutin, and Ronald D. Neumann. 14. Targeted Genome Modification via Triple Helix Formation: Jennifer M. Kalish and Peter M. Glazer. Part VI: Functional Genomics-Antisense/RNAi. 15. Promoter Array Studies Identify Cohorts of Genes Directly Regulated by Methylation, Copy Number Change, or Transcription Factor Binding in Human Cancer Cells: Yipeng Wang, Jun Hayakawa, Fred Long, Qiuju Yu, Ann H. Cho, Gaelle Rondeau, John Welsh, Shalu Mittal, Ian De Belle, Eileen Adamson, Michael Mcclelland, and Dan Mercola. 16. Application of Expression Genomics for Predicting Treatment Response in Cancer: Khew-Voon Chin, Leah Alabanza, Kazuyuki Fujii, Kazuya Kudoh, Tsunekazu Kita, Yoshihiro Kikuchi, Zachariah E. Selvanayagam, Yick Fu Wong, Yong Lin, and Wei Chung Shih. 17. Stability Regulation of mRNA and the Control of Gene Expression: Chris Cheadle, Jinshui Fan, Yoon S. Cho-Chung, Thomas Werner, Jill Ray, Lana Do, Myriam Gorospe, and Kevin G. Becker. Part VII: Chemosensitivity Enhancement by Antisense and RNAi. 18. Novel MDM2 p53-Independent Functions Identified through RNA Silencing Technologies: Zhuo Zhang, Hui Wang, Mao Li, Elizabeth Rayburn, Sudhir Agrawal, and Ruiwen Zhang. 19. Application of XIAP Antisense to Cancer and Other Proliferative Disorders: Development of AEG35156/ GEM(r)640: Eric C. Lacasse, Ekambar R. Kandimalla, Peter Winocour, Tim Sullivan, Sudhir Agrawal, John W. Gillard, and Jon Durkin. Part VIII: Nucleic Acid Therapeutics for Human Diseases. 20. Induction of Apoptosis by G3139 in Melanoma Cells: Luba Benimetskaya, Johnathan C. Lai, Anastasia Khvorova, Sijian Wu, Paul Miller, and C A Stein. 21. Zebularine: A Unique Molecule for an Epigenetically Based Strategy in Cancer Chemotherapy: Victor E. Marquez, James A. Kelley, Riad Agbaria, Tisipi Ben-Kasus, Jonathan C. Cheng, Christine B. Yoo, and Peter A. Jones. 22. Chemoprevention with Protein Kinase A RI Antisense in DMBA-Mammary Carcinogenesis: Maria V. Nesterova and Yoon S. Cho-Chung" @default.
• W628846560 created "2016-06-24" @default.
• W628846560 creator A5016789863 @default.
• W628846560 creator A5026226715 @default.
• W628846560 creator A5038833981 @default.
• W628846560 date "2005-01-01" @default.
• W628846560 modified "2023-09-23" @default.
• W628846560 title "Therapeutic oligonucleotides : transcriptional and translational strategies for silencing gene expression" @default.
• W628846560 hasPublicationYear "2005" @default.
• W628846560 type Work @default.
• W628846560 sameAs 628846560 @default.
• W628846560 citedByCount "0" @default.
• W628846560 crossrefType "book" @default.
• W628846560 hasAuthorship W628846560A5016789863 @default.
• W628846560 hasAuthorship W628846560A5026226715 @default.
• W628846560 hasAuthorship W628846560A5038833981 @default.
• W628846560 hasConcept C104317684 @default.
• W628846560 hasConcept C119056186 @default.
• W628846560 hasConcept C129312508 @default.
• W628846560 hasConcept C145059251 @default.
• W628846560 hasConcept C153911025 @default.
• W628846560 hasConcept C166703698 @default.
• W628846560 hasConcept C185592680 @default.
• W628846560 hasConcept C24107716 @default.
• W628846560 hasConcept C55493867 @default.
• W628846560 hasConcept C67705224 @default.
• W628846560 hasConcept C86803240 @default.
• W628846560 hasConceptScore W628846560C104317684 @default.
• W628846560 hasConceptScore W628846560C119056186 @default.
• W628846560 hasConceptScore W628846560C129312508 @default.
• W628846560 hasConceptScore W628846560C145059251 @default.
• W628846560 hasConceptScore W628846560C153911025 @default.
• W628846560 hasConceptScore W628846560C166703698 @default.
• W628846560 hasConceptScore W628846560C185592680 @default.
• W628846560 hasConceptScore W628846560C24107716 @default.
• W628846560 hasConceptScore W628846560C55493867 @default.
• W628846560 hasConceptScore W628846560C67705224 @default.
• W628846560 hasConceptScore W628846560C86803240 @default.
• W628846560 hasLocation W6288465601 @default.
• W628846560 hasOpenAccess W628846560 @default.
• W628846560 hasPrimaryLocation W6288465601 @default.
• W628846560 hasRelatedWork W1246092528 @default.
• W628846560 hasRelatedWork W1478604736 @default.
• W628846560 hasRelatedWork W1550146907 @default.
• W628846560 hasRelatedWork W1552545829 @default.
• W628846560 hasRelatedWork W1604073273 @default.
• W628846560 hasRelatedWork W212351281 @default.
• W628846560 hasRelatedWork W2189599180 @default.
• W628846560 hasRelatedWork W2338343138 @default.
• W628846560 hasRelatedWork W2950859937 @default.
• W628846560 hasRelatedWork W2996166713 @default.
• W628846560 hasRelatedWork W3001004095 @default.
• W628846560 hasRelatedWork W408313342 @default.
• W628846560 hasRelatedWork W565483693 @default.
• W628846560 hasRelatedWork W566122923 @default.
• W628846560 hasRelatedWork W570606785 @default.
• W628846560 hasRelatedWork W572339647 @default.
• W628846560 hasRelatedWork W582841148 @default.
• W628846560 hasRelatedWork W615553497 @default.
• W628846560 hasRelatedWork W623861257 @default.
• W628846560 hasRelatedWork W642328518 @default.
• W628846560 isParatext "false" @default.
• W628846560 isRetracted "false" @default.
• W628846560 magId "628846560" @default.
• W628846560 workType "book" @default.